Diabetes Studies

 

 

Study To Qualify
Type 2 Diabetes, New Once Weekly GLP/GIP agonist vs. Lantus Insulin, No Placebo Currently Taking up to three Oral Diabetic medications with an HBA1c of 7.5 to 10.5. view
Type 1 Diabetes, New Bolus Insulin vs. Novolog Insulin, No Placebo Currently Taking Stable Lantus/Toujeo Insulin and Novolog or Humalog with an HBA1c of 6.5 to 10.0. view
Type 1 Diabetes, New Once Weekly Glucagon Receptor Antibody medication Currently Taking Stable Basal/Bolus Insulin or on an Insulin Pump with an HBA1c of  7.0 to 10.0.

 

Comments are closed.